Tandem Diabetes Care (TNDM) Interest Expenses (2013 - 2026)

Tandem Diabetes Care's Interest Expenses history runs 14 years deep, the most recent figure standing at $170.0 million for Q1 2026.

• Quarterly Interest Expenses rose 1708.84% year-over-year to $170.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170.0 million (up 1708.84% YoY) and the FY2025 annual result came in at $270.3 million, up 28.47% from the prior year.
• Interest Expenses was $170.0 million for Q1 2026 at Tandem Diabetes Care, up from $15.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $182.6 million in Q2 2025 and bottomed at -$2.2 million in Q4 2024.
• A 5-year average of $27.3 million and a median of $6.7 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses slumped 136.95% — and 2025, when it soared 1842.18%.
• Tandem Diabetes Care's Interest Expenses stood at $30.2 million in 2022, then plunged by 80.75% to $5.8 million in 2023, then sank by 136.95% to -$2.2 million in 2024, then jumped by 798.47% to $15.0 million in 2025, then jumped by 1031.73% to $170.0 million in 2026.
• Business Quant data shows TNDM's Interest Expenses at $170.0 million in Q1 2026, $15.0 million in Q4 2025, and $6.7 million in Q3 2025.